Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00903266 · ClinicalTrials.gov registry record · Phase 3

Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia

A Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
Phase 3
Development phase
30
Enrollment target

NCT00903266 is a Phase 3 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00903266, a Phase 3 study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
Phase 3
Development phase
30 participants
Enrollment target

Study Summary

We are doing this clinical trial in order to evaluate two different treatments for non-fluent aphasia: Melodic Intonation Therapy (MIT) and Speech Repetition Therapy (SRT). MIT uses a simple form of singing, while SRT uses intensive repetition of a set of words and phrases. We want to see which intensive form of treatment is more effective in leading to an improvement in speech output compared to a no-therapy control period, and whether either treatment can cause changes in brain activity during speaking and changes in brain structure. We will use a technique known as functional Magnetic Resonance Imaging (fMRI) to measure blood flow changes in the brain and structural MRI that assess brain anatomy and connections between brain regions. We will use fMRI to assess brain activity while a patient speaks, sings, and hums. We will assess changes in brain activity and in brain structure by comparing scans done prior to treatment to scans obtained after treatment and we will also examine changes between treatment groups. We will correlate changes in brain activity and brain structure with changes in language test scores.

Interventions

  • BEHAVIORAL Melodic Intonation Therapy
  • BEHAVIORAL Speech-Repetition-Therapy

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2008-02
Est. Completion 2020-06
Phase Phase 3

What the Registry Record Tells You About NCT00903266

The ClinicalTrials.gov registry entry for NCT00903266 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Melodic Intonation Therapy is the first listed.

NCT00903266 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00903266 about?

NCT00903266 is a clinical study titled "Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia". We are doing this clinical trial in order to evaluate two different treatments for non-fluent aphasia: Melodic Intonation Therapy (MIT) and Speech Repetition Therapy (SRT). MIT uses a simple form of singing, while SRT uses intensive repetition of a set of words and phrases. We want to see which inte...

What is the current status of trial NCT00903266?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2008-02. Estimated completion is 2020-06.

What interventions are being tested in trial NCT00903266?

The interventions under investigation include: Melodic Intonation Therapy (BEHAVIORAL), Speech-Repetition-Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00903266?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.